| Attribute |
Value |
| 52 Week Change |
-0.5145519 |
| Address1 |
10 Sylvan Way |
| All Time High |
249.27 |
| All Time Low |
28.14 |
| Ask |
75.3 |
| Ask Size |
300 |
| Audit Risk |
5 |
| Average Analyst Rating |
2.0 - Buy |
| Average Daily Volume10 Day |
6,866,800 |
| Average Daily Volume3 Month |
7,168,521 |
| Average Volume |
7,168,521 |
| Average Volume10Days |
6,866,800 |
| Beta |
0.749 |
| Bid |
74.61 |
| Bid Size |
100 |
| Board Risk |
2 |
| Book Value |
7.839 |
| City |
Parsippany |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
6 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
75.39 |
| Current Ratio |
3.153 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
76.5 |
| Day Low |
74.53 |
| Debt To Equity |
286.236 |
| Display Name |
Zoetis |
| Dividend Date |
1,788,220,800 |
| Dividend Rate |
2.12 |
| Dividend Yield |
2.81 |
| Earnings Call Timestamp End |
1,786,046,400 |
| Earnings Call Timestamp Start |
1,786,046,400 |
| Earnings Growth |
0.06 |
| Earnings Quarterly Growth |
-0.002 |
| Earnings Timestamp |
1,786,019,400 |
| Earnings Timestamp End |
1,786,019,400 |
| Earnings Timestamp Start |
1,786,019,400 |
| Ebitda |
4,073,999,872 |
| Ebitda Margins |
0.42745 |
| Enterprise To Ebitda |
9.553 |
| Enterprise To Revenue |
4.083 |
| Enterprise Value |
38,918,606,848 |
| Eps Current Year |
6.86897 |
| Eps Forward |
7.391 |
| Eps Trailing Twelve Months |
6.1 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,784,505,600 |
| Exchange |
NYQ |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
82.085 |
| Fifty Day Average Change |
-6.6949997 |
| Fifty Day Average Change Percent |
-0.0815618 |
| Fifty Two Week Change Percent |
-51.45519 |
| Fifty Two Week High |
160.48 |
| Fifty Two Week High Change |
-85.09 |
| Fifty Two Week High Change Percent |
-0.5302218 |
| Fifty Two Week Low |
71.47 |
| Fifty Two Week Low Change |
3.9199982 |
| Fifty Two Week Low Change Percent |
0.05484816 |
| Fifty Two Week Range |
71.47 - 160.48 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,359,729,000,000 |
| Five Year Avg Dividend Yield |
0.95 |
| Float Shares |
418,377,085 |
| Forward Eps |
7.391 |
| Forward P E |
10.200244 |
| Free Cashflow |
1,780,875,008 |
| Full Exchange Name |
NYSE |
| Full Time Employees |
14,500 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,782,864,000 |
| Gross Margins |
0.71839 |
| Gross Profits |
6,847,000,064 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.00154 |
| Held Percent Institutions |
1.0296199 |
| Implied Shares Outstanding |
419,228,118 |
| Industry |
Drug Manufacturers - Specialty & Generic |
| Industry Disp |
Drug Manufacturers - Specialty & Generic |
| Industry Key |
drug-manufacturers-specialty-generic |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Dividend Date |
1,776,643,200 |
| Last Dividend Value |
0.53 |
| Last Fiscal Year End |
1,767,139,200 |
| Long Business Summary |
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey. |
| Long Name |
Zoetis Inc. |
| Market |
us_market |
| Market Cap |
31,605,608,448 |
| Market State |
POST |
| Max Age |
86,400 |
| Message Board Id |
finmb_215548781 |
| Most Recent Quarter |
1,774,915,200 |
| Net Income To Common |
2,672,000,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
31,676,876,596 |
| Number Of Analyst Opinions |
17 |
| Open |
75.9 |
| Operating Cashflow |
2,790,000,128 |
| Operating Margins |
0.36561 |
| Overall Risk |
4 |
| Payout Ratio |
0.3328 |
| Peg Ratio |
1.81 |
| Phone |
973 822 7000 |
| Post Market Change |
-0.15999603 |
| Post Market Change Percent |
-0.21222448 |
| Post Market Price |
75.23 |
| Post Market Time |
1,783,986,332 |
| Previous Close |
75.56 |
| Price Eps Current Year |
10.975445 |
| Price Hint |
2 |
| Price To Book |
9.617298 |
| Price To Sales Trailing12 Months |
3.3160853 |
| Profit Margins |
0.28035 |
| Quick Ratio |
1.679 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
buy |
| Recommendation Mean |
2.05 |
| Region |
US |
| Regular Market Change |
-0.169998 |
| Regular Market Change Percent |
-0.224984 |
| Regular Market Day High |
76.5 |
| Regular Market Day Low |
74.53 |
| Regular Market Day Range |
74.53 - 76.5 |
| Regular Market Open |
75.9 |
| Regular Market Previous Close |
75.56 |
| Regular Market Price |
75.39 |
| Regular Market Time |
1,783,972,910 |
| Regular Market Volume |
5,713,454 |
| Return On Assets |
0.15525 |
| Return On Equity |
0.67748 |
| Revenue Growth |
0.029 |
| Revenue Per Share |
21.807 |
| Sand P52 Week Change |
0.20847368 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
7 |
| Shares Outstanding |
419,228,118 |
| Shares Percent Shares Out |
0.038 |
| Shares Short |
15,923,322 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
13,462,233 |
| Short Name |
Zoetis Inc. |
| Short Percent Of Float |
0.0429 |
| Short Ratio |
2.15 |
| Source Interval |
15 |
| State |
NJ |
| Symbol |
ZTS |
| Target High Price |
160.0 |
| Target Low Price |
85.0 |
| Target Mean Price |
115.64706 |
| Target Median Price |
112.0 |
| Total Cash |
1,940,999,936 |
| Total Cash Per Share |
4.63 |
| Total Debt |
9,253,999,616 |
| Total Revenue |
9,530,999,808 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
2.03 |
| Trailing Annual Dividend Yield |
0.026866067 |
| Trailing Eps |
6.1 |
| Trailing P E |
12.359016 |
| Trailing Peg Ratio |
1.8109 |
| Triggerable |
1 |
| Two Hundred Day Average |
115.5543 |
| Two Hundred Day Average Change |
-40.1643 |
| Two Hundred Day Average Change Percent |
-0.34757945 |
| Type Disp |
Equity |
| Volume |
5,713,454 |
| Website |
https://www.zoetis.com |
| Zip |
7,054 |